RaySearch Laboratories has received an order from China-based radiation therapy machine manufacturer Shinva Medical Instrument for RayPlan treatment planning systems.
As part of the agreement, RaySearch will supply 15 RayPlan systems to Shinva, who will market these systems to its customers in China.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
RayPlan is designed to make RayStation technology accessible to clinics that require a streamlined solution.
It supports a range of treatment planning activities for 3D-CRT, VMAT, IMRT, TomoTherapy and electron beam radiation therapy.
Shinva general manager Gery Zhao said: “I am delighted about our cooperation with RaySearch and I’m confident that this partnership will pave the way for success in the Chinese market. At Shinva, we are committed to taking advantage of the new market opportunities in the upcoming year.”
RaySearch has been supplying RayStation treatment planning systems to Shinva for many years.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataThese systems combine adaptive therapy capabilities and advanced algorithms for treatment plan enhancement for HDR brachytherapy and external beam therapy with electrons, photons, protons and helium and carbon ions.
Shinva marketed these systems along with its linear accelerators to its customers in China.
RaySearch founder and CEO Johan Löf said: “This order from Shinva is indicative of the strong position that Shinva has in the Chinese market. We appreciate the partnership with Shinva and that they and their customers in China choose RayPlan as their treatment planning system.
“The Chinese market has great potential for the future and we look forward to a continued strong collaboration with Shinva.”
